Back to company

SIMULPHARMA ApS: Financial statements 2022

CVR: 32832075

SIMULPHARMA ApS (CVR 32832075) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 484,388 and a net result of DKK -58,155 compared with DKK -83,269 the year before. That is a decrease of 23.8% compared with the year before. The profit margin was -12%. Equity amounted to DKK 79,818. The solvency ratio was 88.2%. The company had 1 employee in the financial year.

Revenue
484,388 kr.
Gross Profit
406,469 kr.
Profit/Loss
-58,155 kr.
Equity
79,818 kr.
Total Assets
90,450 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022484 t.406 t.-58 t.80 t.1
2021636 t.636 t.-83 t.138 t.1
2020719 t.719 t.36 t.221 t.1
2019905 t.-15 t.-13 t.185 t.1
2018958 t.955 t.30 t.198 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on SIMULPHARMA ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

SIMULPHARMA ApS: The 2021 annual report is outJun 27, 2022

SIMULPHARMA ApS has published its annual report for 2021. Revenue came to DKK 635,995, and the net result was DKK -83,269.

About SIMULPHARMA ApS

SIMULPHARMA ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2010. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The management consists of Gunnlaugur Halldorsson. The company is owned by Gunnlaugur Halldorsson. The company has 1 employee. In 2024, the company reported revenue of DKK 158,958 and a net result of DKK 41,292 compared with DKK -57,341 the year before. Equity amounted to DKK 63,769.